A detailed history of Napatree Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Napatree Capital LLC holds 1,297 shares of AMGN stock, worth $414,495. This represents 0.33% of its overall portfolio holdings.

Number of Shares
1,297
Previous 1,297 -0.0%
Holding current value
$414,495
Previous $405 Million -0.0%
% of portfolio
0.33%
Previous 0.33%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $21,808 - $26,502
83 Added 6.84%
1,297 $405 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $8,066 - $9,736
-30 Reduced 2.41%
1,214 $333 Million
Q4 2023

Mar 26, 2024

BUY
$255.7 - $288.46 $318,090 - $358,844
1,244 New
1,244 $358 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Napatree Capital LLC Portfolio

Follow Napatree Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Napatree Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Napatree Capital LLC with notifications on news.